Description

Semaglutide is a potent, long-acting analogue of the naturally occurring hormone Glucagon-Like Peptide-1 (GLP-1). By mimicking the action of incretin hormones, Semaglutide is primarily researched for its ability to enhance glucose-dependent insulin secretion, suppress inappropriate glucagon release, and significantly delay gastric emptying. It is the primary reference compound for modern studies into adipose tissue reduction and the modulation of appetite-signaling pathways in the hypothalamus.

Our Semaglutide is 99%+ pure, lyophilized for maximum stability, and vacuum-sealed to ensure consistent research results in endocrine and metabolic studies.

Key Research Applications & Benefits

• Incretin Pathway Modulation: Directly activates GLP-1 receptors to study the enhancement of pancreatic beta-cell function and insulin sensitivity.

• Gastric Emptying Regulation: Research focuses on its ability to slow the transit of nutrients, providing a model for prolonged satiety and calorie-intake reduction.

• Weight-Regulation Studies: Extensively used to investigate the mechanisms of significant weight reduction and the preservation of metabolic health.

• Cardiovascular Research: Studied for its potential role in reducing systemic inflammation and improving cardiovascular markers in high-risk research models.

• Neuroendocrine Signaling: Investigated for its impact on the brain’s reward centers, specifically regarding the suppression of cravings and hunger signals.

Technical Specifications